Immunization, measles in Europe & Central Asia
Europe & Central Asia: Immunization, measles was 94.1% in 2024. ▲ Rising
Immunization, measles in Europe & Central Asia, 1992–2024
Source: World Health Organization (WHO). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, measles in Europe & Central Asia is 94.1%, measured in 2024.
That represents a change of down 0.2% on the previous year and up 0.8% over ten years.
Over the whole period, immunization, measles in Europe & Central Asia peaked at 95.4% in 2019 and was at its lowest, 81.3%, in 1992.
Europe & Central Asia ranks 7th of 47 groups on this measure, in the top quarter.
The long-run direction has been consistently rising across the 33 years of available data.
Immunization, measles in Europe & Central Asia, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1992 | 81.3% | — |
| 1993 | 82.7% | +1.8% |
| 1994 | 82.7% | +0.0% |
| 1995 | 83.9% | +1.4% |
| 1996 | 86.2% | +2.7% |
| 1997 | 88.1% | +2.2% |
| 1998 | 88.1% | +0.0% |
| 1999 | 89.5% | +1.6% |
| 2000 | 90.8% | +1.4% |
| 2001 | 91.6% | +1.0% |
| 2002 | 90.9% | -0.8% |
| 2003 | 90.5% | -0.5% |
| 2004 | 91.5% | +1.2% |
| 2005 | 93.1% | +1.7% |
| 2006 | 94.3% | +1.4% |
| 2007 | 94.6% | +0.3% |
| 2008 | 94.7% | +0.1% |
| 2009 | 93.7% | -1.1% |
| 2010 | 93.4% | -0.3% |
| 2011 | 94.2% | +0.8% |
| 2012 | 94.7% | +0.6% |
| 2013 | 94.9% | +0.2% |
| 2014 | 93.3% | -1.7% |
| 2015 | 93.6% | +0.3% |
| 2016 | 93.1% | -0.6% |
| 2017 | 94.9% | +2.0% |
| 2018 | 95.0% | +0.1% |
| 2019 | 95.4% | +0.4% |
| 2020 | 93.9% | -1.6% |
| 2021 | 94.4% | +0.5% |
| 2022 | 93.9% | -0.6% |
| 2023 | 94.3% | +0.4% |
| 2024 | 94.1% | -0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 85.3% | 81.3% | 89.5% | 8 |
| 2000s | 92.6% | 90.5% | 94.7% | 10 |
| 2010s | 94.2% | 93.1% | 95.4% | 10 |
| 2020s | 94.1% | 93.9% | 94.4% | 5 |
More health data for Europe & Central Asia
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 45-49, male, per capita 0.0339 units per person (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0299 units per person (2025)
- Population ages 45-49, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0346 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, male, annual growth rate 0.6344 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
Frequently asked questions
- What is immunization, measles in Europe & Central Asia?
- Immunization, measles in Europe & Central Asia was 94.1% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, measles recorded in Europe & Central Asia?
- The highest recorded value was 95.4% in 2019.
- What is the lowest immunization, measles recorded in Europe & Central Asia?
- The lowest recorded value was 81.3% in 1992.
- How does Europe & Central Asia rank for immunization, measles?
- Europe & Central Asia ranks 7th out of 47 groups with data for 2024.
- Is immunization, measles rising or falling in Europe & Central Asia?
- Over the last ten years it is up 0.8%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, measles (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.